FemiClear Yeast Infection (femiclear 2 day simple) NDC 71042-026

NDC codes

FDA NDC Directory

Product NDC (as listed)71042-026Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71042-0026Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71042-026-14	71042002614	1 TUBE in 1 CARTON (71042-026-14) / .0142 kg in 1 TUBEMarketed from Jan 17, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): FemiClear Yeast Infection
Generic name (nonproprietary): femiclear 2 day simple
Active ingredients: Cajuput oil — .1 kg/kgCalendula officinalis whole — 1 kg/kg
Dosage form: Ointment
Route: Topical
Labeler: OrganiCare Nature's Science, LLC
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 17, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 71042-026_419b5986-6754-8f80-e063-6294a90a696aSPL ID 419b5986-6754-8f80-e063-6294a90a696aSPL set ID f27b4b75-eb2d-5da0-e053-2a95a90ae155UNII J3TO6BUQ37, PFR03EBU0H

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471042002614 followed by a unit qualifier and the quantity

Package 71042-0026-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 20, 2025.

Indications (excerpt from the label)

Uses Treats vaginal yeast infections

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)